Literature DB >> 19224318

Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2.

Martina Minnerop1, Eileen Luders, Karsten Specht, Jürgen Ruhlmann, Christiane Schneider-Gold, Rolf Schröder, Paul M Thompson, Arthur W Toga, Thomas Klockgether, Cornelia Kornblum.   

Abstract

Myotonic dystrophy type 2 (DM2) is an autosomal dominantly inherited multisystemic disorder and a common cause of muscular dystrophy in adults. Although neuromuscular symptoms predominate, there is clinical and imaging evidence of cerebral involvement. We used voxel-based morphometry (VBM) based on T1-weighted magnetic resonance images to investigate brain morphology in 13 DM2 patients in comparison to 13 sex- and age-matched controls. Further, we employed novel computational surface-based methods that specifically assess callosal thickness. We found grey and white matter loss along cerebral midline structures in our patient group. Grey matter reductions were present in brainstem and adjacent hypothalamic and thalamic regions, while white matter was mainly reduced in corpus callosum. The reduced callosal size was highly significant and independently confirmed by different methods. Our data provide first evidence for grey and white matter loss along brain midline structures in DM2 patients. The reduced size of the corpus callosum further extends the spectrum of white matter changes in DM2 and may represent the morphological substrate of neuropsychological abnormalities previously described in this disorder.

Entities:  

Mesh:

Year:  2008        PMID: 19224318      PMCID: PMC2770432          DOI: 10.1007/s00415-008-0997-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Relationship between diffusion tensor imaging and brain morphology in patients with myotonic dystrophy.

Authors:  Miho Ota; Noriko Sato; Yasushi Ohya; Yoshitsugu Aoki; Katsuyoshi Mizukami; Takeyuki Mori; Takashi Asada
Journal:  Neurosci Lett       Date:  2006-09-15       Impact factor: 3.046

3.  The association of macro- and microstructure of the corpus callosum and language lateralisation.

Authors:  René Westerhausen; Frank Kreuder; Sarah Dos Santos Sequeira; Christof Walter; Wolfgang Woerner; Ralf Arne Wittling; Elisabeth Schweiger; Werner Wittling
Journal:  Brain Lang       Date:  2005-09-12       Impact factor: 2.381

4.  Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1.

Authors:  Stefan Vielhaber; Sibylle Jakubiczka; Charly Gaul; Mircea Ariel Schoenfeld; Grazyna Debska-Vielhaber; Stefan Zierz; Hans-Jochen Heinze; Heiko G Niessen; Jörn Kaufmann
Journal:  Muscle Nerve       Date:  2006-08       Impact factor: 3.217

5.  Parasagittal asymmetries of the corpus callosum.

Authors:  E Luders; K L Narr; E Zaidel; P M Thompson; L Jancke; A W Toga
Journal:  Cereb Cortex       Date:  2005-05-18       Impact factor: 5.357

6.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; E Fisher; J C Lee; J Simon; L Jacobs
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

7.  Cognitive impairment in adult myotonic dystrophies: a longitudinal study.

Authors:  V Sansone; S Gandossini; M Cotelli; M Calabria; O Zanetti; G Meola
Journal:  Neurol Sci       Date:  2007-03       Impact factor: 3.307

8.  Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.

Authors:  N Evangelou; D Konz; M M Esiri; S Smith; J Palace; P M Matthews
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

Review 9.  Cerebral involvement in myotonic dystrophies.

Authors:  Giovanni Meola; Valeria Sansone
Journal:  Muscle Nerve       Date:  2007-09       Impact factor: 3.217

10.  The hypocretin neurotransmission system in myotonic dystrophy type 1.

Authors:  E Ciafaloni; E Mignot; V Sansone; J E Hilbert; L Lin; X Lin; L C Liu; W R Pigeon; M L Perlis; C A Thornton
Journal:  Neurology       Date:  2008-01-15       Impact factor: 9.910

View more
  12 in total

1.  Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.

Authors:  Stojan Peric; Gorana Mandic-Stojmenovic; Elka Stefanova; Dusanka Savic-Pavicevic; Jovan Pesovic; Vera Ilic; Valerija Dobricic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2014-10-28       Impact factor: 4.849

2.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

Review 3.  Pathogenic RNAs in microsatellite expansion disease.

Authors:  Jihae Shin; Konstantinos Charizanis; Maurice S Swanson
Journal:  Neurosci Lett       Date:  2009-08-04       Impact factor: 3.046

4.  Diffusion tensor imaging reveals widespread white matter abnormalities in children and adolescents with myotonic dystrophy type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Christopher J Bell; Ryan L Muetzel; Kelvin O Lim; John W Day
Journal:  J Neurol       Date:  2012-11-29       Impact factor: 4.849

5.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

6.  Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.

Authors:  Christiane Schneider-Gold; Barabara Bellenberg; Christian Prehn; Christos Krogias; Ruth Schneider; Jan Klein; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 7.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

Review 8.  Brain Parenchymal Fraction in Healthy Adults-A Systematic Review of the Literature.

Authors:  Mattias Vågberg; Gabriel Granåsen; Anders Svenningsson
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

Review 9.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

Review 10.  Current Progress in CNS Imaging of Myotonic Dystrophy.

Authors:  Martina Minnerop; Carla Gliem; Cornelia Kornblum
Journal:  Front Neurol       Date:  2018-08-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.